Loading

Scalable Biomanufacturing for Living Medicines: Pioneering the Future Today

June 17, 2025
Breakout Session
Biomanufacturing
209
As the demand for personalized therapies increases, the ability to efficiently produce living medicines at scale is more critical than ever. This session will explore cutting-edge advancements in biomanufacturing technologies, including automation, AI integration, and novel production methods. Panelists will share their insights on overcoming the challenges of scalability, ensuring quality and safety, and navigating regulatory landscapes. Don’t miss this opportunity to hear from industry leaders and innovators in this dynamic panel as they discuss the future of scalable biomanufacturing for living medicines and how the future of medicine is being engineered.
Moderator
Marinna Madrid, PhD
Co-Founder and Chief Product Officer
Cellino
Speakers
Julie O’Shaughnessy
Chief Operating Officer
Vivodyne
Bruna Paulsen, PhD
VP, Manufacturing and Therapeutic Development
Gameto
Kate Rochlin, PhD
Chief Operating Officer
IN8bio
Alexis Rovner, PhD
CEO & Founder
64x Bio
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS